How HCTZ Lowers Blood Pressure
HCTZ lowers blood pressure by blocking sodium and chloride reabsorption in the kidney's distal tubule, which initially causes fluid loss, but with continued use, the main effect is reducing peripheral vascular resistance through direct blood vessel relaxation. 1
Mechanism of Action
Initial Phase (First Few Weeks)
- Sodium and water elimination: HCTZ blocks the reabsorption of sodium and chloride ions in the distal tubule, increasing sodium excretion and water loss 1
- This leads to reduced blood volume and cardiac output initially
- Blood pressure drops as a result of this diuretic effect
Chronic Phase (Long-term Use)
- Peripheral vasodilation becomes the primary mechanism: After several weeks, plasma volume returns toward normal, but peripheral vascular resistance decreases 1
- The exact mechanism of this sustained antihypertensive effect is not fully understood, but it involves direct vasodilatory effects on blood vessels 1
- Some evidence suggests increased prostacyclin (PGI2) synthesis in responders, which causes blood vessel relaxation 2
Blood Pressure Reduction
- Dose-dependent effect: HCTZ lowers blood pressure based on dose 3:
- 12.5 mg daily: reduces BP by 6/3 mmHg
- 25 mg daily: reduces BP by 8/3 mmHg
- 50 mg daily: reduces BP by 11/5 mmHg
- Onset occurs within 2 hours, peaks at 4 hours, and lasts up to 24 hours 1
- Greater effect on systolic than diastolic pressure 3
Important Metabolic Effects
With continued use, compensatory mechanisms cause:
- Potassium loss (dose-related) 1
- Decreased calcium excretion
- Increased uric acid retention
- Possible increases in glucose, cholesterol, and triglycerides 1, 3
Bottom line: HCTZ works by making your kidneys eliminate more salt and water initially, then by relaxing blood vessels over time.